person · Reporting owner
Goldschmidt, MD Pascal J
Disclosed activity across 1 company
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Pediatrix Medical Group, Inc.MD · Entity 4451 | Director | February 13, 2020 | February 18, 2020 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Pediatrix Medical Group, Inc.
Report date February 13, 2020 · Filed February 18, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 15,538 |
Reported balance
After 2020-02-13 transaction · row 1
1 source rowRow 1 · 2020-02-13 · Grant · Acquired 4,717 · Balance 15,538 F1: Restricted shares granted pursuant to Issuer's Amended and Restated 2008 Incentive Compensation Plan, in connection with annual equity award. Shares will vest in three equal installments on March 1, 2021, March 1, 2022 and March 1, 2023. |
Filing footnotes · ownership attribution and instrument terms
F1: Restricted shares granted pursuant to Issuer's Amended and Restated 2008 Incentive Compensation Plan, in connection with annual equity award. Shares will vest in three equal installments on March 1, 2021, March 1, 2022 and March 1, 2023.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 13, 2020 Filed Feb 18, 2020 23:04 UTC | Pediatrix Medical Group, Inc. MD · Entity 4451 | GrantCommon Stock | 4,717 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-010328 · doc4.xml · nonDerivative · entry 1 Goldschmidt, MD Pascal J · CIK 0001356123 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,538 F1 · kind: Restricted shares granted pursuant to Issuer's Amended and Restated 2008 Incentive Compensation Plan, in connection with annual equity award. Shares will vest in three equal installments on March 1, 2021, March 1, 2022 and March 1, 2023. Read SEC document |
| November 01, 2019 Filed Nov 1, 2019 20:58 UTC | Pediatrix Medical Group, Inc. MD · Entity 4451 | SaleCommon Stock | 5,000 | $22.88 | $114,403.00 |
DisclosureSEC source: 0001209191-19-054736 · doc4.xml · nonDerivative · entry 1 Goldschmidt, MD Pascal J · CIK 0001356123 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,821 F1 · kind: Sales made pursuant to Reporting Person's 10b5-1 trading plan and a domestic relations order. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in seventeen (17) separate transactions with prices ranging from $22.51 to $23.00 for an average weighted sale price of $22.8806. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this section. Read SEC document |
| September 03, 2019 Filed Sep 4, 2019 20:44 UTC | Pediatrix Medical Group, Inc. MD · Entity 4451 | SaleCommon Stock | 5,000 | $20.81 | $104,050.00 |
DisclosureSEC source: 0001209191-19-048228 · doc4.xml · nonDerivative · entry 1 Goldschmidt, MD Pascal J · CIK 0001356123 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,821 F1 · kind: Sales made pursuant to Reporting Person's 10b5-1 trading plan and pursuant to a domestic relations order. Read SEC document |
| March 13, 2019 Filed Mar 15, 2019 21:36 UTC | Pediatrix Medical Group, Inc. MD · Entity 4451 | SaleCommon Stock | 3,300 | $30.40 | $100,330.89 |
DisclosureSEC source: 0001209191-19-019780 · doc4.xml · nonDerivative · entry 1 Goldschmidt, MD Pascal J · CIK 0001356123 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,821 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in five separate transactions with prices ranging from $30.39 to $30.43 for an average weighted sales price of $30.4033. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this section. Read SEC document |
| February 12, 2019 Filed Feb 14, 2019 21:36 UTC | Pediatrix Medical Group, Inc. MD · Entity 4451 | GrantCommon Stock | 3,699 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-010197 · doc4.xml · nonDerivative · entry 1 Goldschmidt, MD Pascal J · CIK 0001356123 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,121 F1 · kind: Restricted shares granted pursuant to Issuer's Amended and Restated 2008 Incentive Compensation Plan, as amended, in connection with annual equity award. Shares will vest in three equal installments on March 1, 2020, March 1, 2021 and March 1, 2022. Read SEC document |
| March 01, 2018 Filed Mar 2, 2018 22:01 UTC | Pediatrix Medical Group, Inc. MD · Entity 4451 | GrantCommon Stock | 2,350 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-015784 · doc4.xml · nonDerivative · entry 1 Goldschmidt, MD Pascal J · CIK 0001356123 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,422 F1 · shares: Restricted shares granted pursuant to Issuer's Amended and Restated 2008 Incentive Compensation Plan, as amended, in connection with annual equity award. Shares will vest in three equal installments on March 1, 2019, March 1, 2020 and March 1, 2021. Read SEC document |
| June 14, 2017 Filed Jun 14, 2017 20:51 UTC | Pediatrix Medical Group, Inc. MD · Entity 4451 | SaleCommon Stock | 1,969 | $57.57 | $113,355.33 |
DisclosureSEC source: 0001209191-17-039857 · doc4.xml · nonDerivative · entry 1 Goldschmidt, MD Pascal J · CIK 0001356123 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,072 Read SEC document |
| June 01, 2017 Filed Jun 2, 2017 20:41 UTC | Pediatrix Medical Group, Inc. MD · Entity 4451 | GrantCommon Stock | 2,292 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-037312 · doc4.xml · nonDerivative · entry 1 Goldschmidt, MD Pascal J · CIK 0001356123 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,041 F1 · shares: Restricted shares granted pursuant to Issuer's Amended and Restated 2008 Incentive Compensation Plan, as amended, in connection with annual equity award. Shares will vest in three equal installments on June 1, 2018, June 1, 2019 and June 1, 2020. Read SEC document |
| February 10, 2017 Filed Feb 13, 2017 21:50 UTC | Pediatrix Medical Group, Inc. MD · Entity 4451 | Exercise / conversionStock Options (Right to Buy) · Derivative | 8,280 | $36.25 Strike: $36.25 | $300,150.00 |
DisclosureSEC source: 0001209191-17-010046 · doc4.xml · derivative · entry 9 Goldschmidt, MD Pascal J · CIK 0001356123 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,280 shares Expires 2021-05-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 10, 2017 Filed Feb 13, 2017 21:50 UTC | Pediatrix Medical Group, Inc. MD · Entity 4451 | Exercise / conversionStock Options (Right to Buy) · Derivative | 9,922 | $29.36 Strike: $29.36 | $291,260.31 |
DisclosureSEC source: 0001209191-17-010046 · doc4.xml · derivative · entry 8 Goldschmidt, MD Pascal J · CIK 0001356123 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 9,922 shares Expires 2020-05-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 10, 2017 Filed Feb 13, 2017 21:50 UTC | Pediatrix Medical Group, Inc. MD · Entity 4451 | Exercise / conversionStock Options (Right to Buy) · Derivative | 10,668 | $27.72 Strike: $27.72 | $295,663.62 |
DisclosureSEC source: 0001209191-17-010046 · doc4.xml · derivative · entry 7 Goldschmidt, MD Pascal J · CIK 0001356123 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,668 shares Expires 2018-05-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 10, 2017 Filed Feb 13, 2017 21:50 UTC | Pediatrix Medical Group, Inc. MD · Entity 4451 | Exercise / conversionStock Options (Right to Buy) · Derivative | 818 | $32.33 Strike: $32.33 | $26,441.85 |
DisclosureSEC source: 0001209191-17-010046 · doc4.xml · derivative · entry 6 Goldschmidt, MD Pascal J · CIK 0001356123 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 818 shares Expires 2017-11-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 10, 2017 Filed Feb 13, 2017 21:50 UTC | Pediatrix Medical Group, Inc. MD · Entity 4451 | SaleCommon Stock | 25,294 | $67.82 | $1,715,317.67 |
DisclosureSEC source: 0001209191-17-010046 · doc4.xml · nonDerivative · entry 5 Goldschmidt, MD Pascal J · CIK 0001356123 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,749 F1 · price: Sales of shares were made in thirty-three (33) separate transactions with prices ranging from $67.70 to $68.05 for an average weighted sales price of $67.8152. Read SEC document |
| February 10, 2017 Filed Feb 13, 2017 21:50 UTC | Pediatrix Medical Group, Inc. MD · Entity 4451 | Exercise / conversionCommon Stock | 8,280 | $36.25 | $300,150.00 |
DisclosureSEC source: 0001209191-17-010046 · doc4.xml · nonDerivative · entry 4 Goldschmidt, MD Pascal J · CIK 0001356123 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,043 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 10, 2017 Filed Feb 13, 2017 21:50 UTC | Pediatrix Medical Group, Inc. MD · Entity 4451 | Exercise / conversionCommon Stock | 9,922 | $29.36 | $291,260.31 |
DisclosureSEC source: 0001209191-17-010046 · doc4.xml · nonDerivative · entry 3 Goldschmidt, MD Pascal J · CIK 0001356123 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,763 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 10, 2017 Filed Feb 13, 2017 21:50 UTC | Pediatrix Medical Group, Inc. MD · Entity 4451 | Exercise / conversionCommon Stock | 10,668 | $27.72 | $295,663.62 |
DisclosureSEC source: 0001209191-17-010046 · doc4.xml · nonDerivative · entry 2 Goldschmidt, MD Pascal J · CIK 0001356123 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,841 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 10, 2017 Filed Feb 13, 2017 21:50 UTC | Pediatrix Medical Group, Inc. MD · Entity 4451 | Exercise / conversionCommon Stock | 818 | $32.33 | $26,441.85 |
DisclosureSEC source: 0001209191-17-010046 · doc4.xml · nonDerivative · entry 1 Goldschmidt, MD Pascal J · CIK 0001356123 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,173 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 10, 2017 Filed Feb 15, 2017 22:04 UTC Amendment | Pediatrix Medical Group, Inc. MD · Entity 4451 | OtherCommon Stock | 25,294 | $67.82 | $1,715,317.67 |
DisclosureSEC source: 0001209191-17-011142 · doc4a.xml · nonDerivative · entry 1 Goldschmidt, MD Pascal J · CIK 0001356123 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,749 F1 · kind: Disposition of shares of Common Stock of the Issuer pursuant to a domestic relations order. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in thirty-three (33) separate transactions with prices ranging from $67.70 to $68.05 for an average weighted sales price of $67.8152. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| December 07, 2016 Filed Dec 21, 2016 22:03 UTC | Pediatrix Medical Group, Inc. MD · Entity 4451 | PurchaseCommon Stock | 2,100 | $66.52 | $139,681.50 |
DisclosureSEC source: 0001209191-16-156355 · doc4.xml · nonDerivative · entry 1 Goldschmidt, MD Pascal J · CIK 0001356123 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,355 Read SEC document |
| September 14, 2016 Filed Sep 16, 2016 20:31 UTC | Pediatrix Medical Group, Inc. MD · Entity 4451 | Exercise / conversionStock Options (Right to Buy) · Derivative | 1,500 | $32.33 Strike: $32.33 | $48,487.50 |
DisclosureSEC source: 0001209191-16-141792 · doc4.xml · derivative · entry 6 Goldschmidt, MD Pascal J · CIK 0001356123 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 818 Underlying: Common Stock · 1,500 shares Expires 2017-11-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 14, 2016 Filed Sep 16, 2016 20:31 UTC | Pediatrix Medical Group, Inc. MD · Entity 4451 | SaleCommon Stock | 156 | $65.03 | $10,144.68 |
DisclosureSEC source: 0001209191-16-141792 · doc4.xml · nonDerivative · entry 5 Goldschmidt, MD Pascal J · CIK 0001356123 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,255 Read SEC document |
| September 14, 2016 Filed Sep 16, 2016 20:31 UTC | Pediatrix Medical Group, Inc. MD · Entity 4451 | SaleCommon Stock | 303 | $65.02 | $19,701.06 |
DisclosureSEC source: 0001209191-16-141792 · doc4.xml · nonDerivative · entry 4 Goldschmidt, MD Pascal J · CIK 0001356123 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,411 Read SEC document |
| September 14, 2016 Filed Sep 16, 2016 20:31 UTC | Pediatrix Medical Group, Inc. MD · Entity 4451 | SaleCommon Stock | 566 | $65.01 | $36,795.66 |
DisclosureSEC source: 0001209191-16-141792 · doc4.xml · nonDerivative · entry 3 Goldschmidt, MD Pascal J · CIK 0001356123 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,714 Read SEC document |
| September 14, 2016 Filed Sep 16, 2016 20:31 UTC | Pediatrix Medical Group, Inc. MD · Entity 4451 | SaleCommon Stock | 475 | $65.00 | $30,875.00 |
DisclosureSEC source: 0001209191-16-141792 · doc4.xml · nonDerivative · entry 2 Goldschmidt, MD Pascal J · CIK 0001356123 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,280 Read SEC document |
| September 14, 2016 Filed Sep 16, 2016 20:31 UTC | Pediatrix Medical Group, Inc. MD · Entity 4451 | Exercise / conversionCommon Stock | 1,500 | $32.33 | $48,487.50 |
DisclosureSEC source: 0001209191-16-141792 · doc4.xml · nonDerivative · entry 1 Goldschmidt, MD Pascal J · CIK 0001356123 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,755 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.